Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Total Equity

Albireo Pharma Inc Total Equity Chart (ALBO)

Albireo Pharma Inc annual/quarterly Total Equity from 2015 to 2020.
  • Albireo Pharma Inc Total Equity for the quarter ending June 06, 2020 was $89m a -14.08% decrease of -13m year over year
  • Albireo Pharma Inc Total Equity for the last 12 months ending June 06, 2020 was $89m a -14.08% decrease of -13m year over year
  • Albireo Pharma Inc Annual Total Equity for 2019 was $93m a -31.64% decrease of -29m from 2018
  • Albireo Pharma Inc Annual Total Equity for 2018 was $123m a 46.79% increase of 57m from 2017
  • Albireo Pharma Inc Annual Total Equity for 2017 was $65m a 43.37% increase of 28m from 2016
Other Balance Sheet Metrics:
  • Albireo Pharma Inc Total Assets for the quarter ending September 09, 2018 was $194m a 62.30% increase of 121m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
View Chart On Koyfin

Quarterly ALBO Total Equity Data

06/2020$89m
03/2020$113m
12/2019$93m
09/2019$102m
06/2019$118m
03/2019$111m
12/2018$123m
09/2018$137m
06/2018$149m
03/2018$160m

Annual ALBO Total Equity Data

2019$93m
2018$123m
2017$65m
2016$37m
2015$-8m
2014$-2m